Pyrido [2,1-a] isoquinoline derivatives

Details Pyrido [2,1-a] isoquinoline derivatives Pyrido [2,1-a] isoquinoline derivatives

2006-10-17

2006-10-17

Seaman, D. Margaret (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S095000, C546S094000

Reexamination Certificate

active

07122555

ABSTRACT:
The present invention provides compounds of formula (I)wherein R1, R2, R3and R4are as indicated in the description, or a pharmaceutically acceptable salt thereof. The compounds are useful for the treatment of diseases which are associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.

REFERENCES:
patent: 5455351 (1995-10-01), Kempf et al.
patent: 6011155 (2000-01-01), Villhauer
patent: 6110949 (2000-08-01), Villhauer
patent: 6124305 (2000-09-01), Villhauer
patent: 6303661 (2001-10-01), Demuth et al.
patent: 6319893 (2001-11-01), Demuth et al.
patent: 6727261 (2004-04-01), Gobbi et al.
patent: 2002/0071838 (2002-06-01), Demuth et al.
patent: 19616486 (1997-10-01), None
patent: 19616486 (1997-10-01), None
patent: 19834591 (2000-02-01), None
patent: 1 308 439 (2003-05-01), None
patent: WO 95/01976 (1995-01-01), None
patent: WO 96/10018 (1996-04-01), None
patent: WO 98/19998 (1998-05-01), None
patent: WO 99/38501 (1999-08-01), None
patent: WO 99/38501 (1999-08-01), None
patent: WO 00/08002 (2000-02-01), None
patent: WO 0034241 (2000-06-01), None
patent: WO 01/19805 (2001-03-01), None
patent: WO 0134594 (2001-05-01), None
patent: WO 01/40180 (2001-06-01), None
patent: WO 01/55105 (2001-08-01), None
patent: WO 0162266 (2001-08-01), None
patent: WO 0230890 (2002-04-01), None
Agarwal, A., et. al., Synth. Commun. (1993) 23, 1101-1110.
Ali, et. al., Pak. J. Sci. Ind. Res., 36, pp. 502-510 (1993).
Carrera, G.M., et. al., Synlett (1994) 1, 93-94.
Collins, J.L., et. al. J. Med Chem. (1998) 41, 5037-5054.
Freedman, J., et. al., J. Heterocycl. Chem. (1990) 27, 343-346.
Francis, et. al., Tetrahedron Ltrs., 28, pp. 5133-5136 (1987).
Golfier, et. al., J. Heterocycl. Chem., 10, pp. 989-991 (1973).
Goto, et. al., Chem. Pharm. Bull, 19, pp. 2050-2057 (1971).
Helv. Chim. Acta (1958) 41, 119.
Horne, et. al., Heterocycles, 39, pp. 139-153 (1994).
Lipp, et. al., Eur. J. Med. Chem., 30 pp. 219-225 (1995).
Novartis AG, Expert Opinion on Therapeutic Patents, Ashley Publications, GB, vol. 10, No. 12, pp. 1937-1942 (2000).
Qizhuang, Y., et.al., J. Med. Chem. (1989) 32, 478-486.
P. Kocienski, Protecting Groups, Thieme Verlag Stuttgart, NY (1994) pp. 192-201.
Schunack, et. al., Z. Naturforschung, 42b, pp. 238-242 (1987).
Singh, et. al., Ind. J. Chem., 22B, pp. 1177-1178 (1983).
TETRAHEDRON (1974), 30, 2157.
TETRAHEDRON Lett. (1984) 25, 3515.
Weintraub, P. M., J. Med. Chem, 15, pp. 419-420 (1972).
Chem. Ber 95, 2132 (1962).
J. Org. Chem (1998) 63, 6715.

Affiliated with

Also associated with

Rating

Pyrido [2,1-a] isoquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrido [2,1-a] isoquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrido [2,1-a] isoquinoline derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3686964